Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.008 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |